M
Marko Sarlija
Researcher at University of Zagreb
Publications - 14
Citations - 417
Marko Sarlija is an academic researcher from University of Zagreb. The author has contributed to research in topics: Cognitive load & Spiking neural network. The author has an hindex of 8, co-authored 14 publications receiving 231 citations.
Papers
More filters
Journal ArticleDOI
Impact of Human Disasters and COVID-19 Pandemic on Mental Health: Potential of Digital Psychiatry.
TL;DR: Scientific evidence regarding adverse impact of diverse human disasters on mental health in afflicted groups and societies and psychosocial impact of COVID-19 as a specific global human disaster is presented, with an emphasis on disturbing mental health aspects of the ongoing pandemic.
Proceedings ArticleDOI
A convolutional neural network based approach to QRS detection
TL;DR: A QRS detection algorithm based on pattern recognition as well as a new approach to ECG baseline wander removal and signal normalization that achieves a sensitivity and positive predictive value comparable with most state-of-the-art solutions.
Journal ArticleDOI
NeuroSense: Short-term emotion recognition and understanding based on spiking neural network modelling of spatio-temporal EEG patterns
TL;DR: In this paper, a short-term emotion recognition framework based on spiking neural network (SNN) modelling of spatio-temporal EEG patterns is presented, where differences between participants' EEG properties are taken into account via subject-dependent spike encoding in the formulated subject independent emotion recognition task.
Journal ArticleDOI
Artificial intelligence in prediction of mental health disorders induced by the COVID-19 pandemic among health care workers
TL;DR: The proposed methodology aims to expand traditionally used subjective self-report predictors of mental health disorders with more objective metrics, which is aligned with the recent literature related to predictive modeling based on artificial intelligence.
Journal ArticleDOI
Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.
Predrag Sikiric,Stipislav Jadrijević,Sven Seiwerth,Tomislav Šoša,Slobodan Dešković,Darko Perović,Gorana Aralica,Zeljko Grabarevic,Rudolf Rucman,Marijan Petek,Vjekoslav Jagić,Branko Turkovic,Tomislav Ziger,Ivo Rotkvić,Stjepan Mise,Ivan Zoricic,Božidar Šebečić,Leonardo Patrlj,Boris Kocman,Marko Sarlija,Darko Mikus,Jadranka Separovic,M. Hanzevacki,Miroslav Gjurašin,Pavle Miklić,Gojko Buljat +25 more
TL;DR: A useful, long-lasting cytoprotective activity (apparently more prominent in BPC 157 rats, than in reference agents, ranitidine, sucralfate, as well as cholestyramine) may be a likely suitable therapy in otherwise resistant reflux oesophagitis conditions.